Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07293728) titled 'A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Oregon Health and Science University
Condition:
Hypertension
Preeclampsia
Intervention:
Drug: Norethindrone 0.35 MG
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: July 2026
Target Sample Size: 50
Countries of Recruitment:
United States
To know more, visi...